| Literature DB >> 31531206 |
Nathalie Erdeljac1, Kathrin Bussmann1, Andrea Schöler2, Finn K Hansen2, Ryan Gilmour1.
Abstract
A chiral, hybrid bioisostere of the CF3 and Et groups (BITE) was installed in a series of vorinostat (Zolinza) analogues, and their histone deacetylase (HDAC) inhibitory behavior was studied relative to that of their nonfluorinated counterparts. Several of these compounds containing the 1,2-difluoroethylene unit showed in vitro potency greater than that of the clinically approved drug itself against HDAC1. This trend was found to be general with the BITE-modified HDAC inhibitors performing significantly better than the ethyl derivatives. Installed by the direct, catalytic vicinal difluorination of terminal alkenes using an I(I)/I(III) manifold, this underexplored chiral bioisostere shows potential in drug discovery.Entities:
Year: 2019 PMID: 31531206 PMCID: PMC6745648 DOI: 10.1021/acsmedchemlett.9b00287
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345